dictamnine has been researched along with Dermatitis, Atopic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, J; Liu, Y; Shao, H; Tang, Z; Wu, G; Yang, N; Yang, Y | 1 |
| Chan, LY; Chang, TM; Hsieh, YT; Huang, HC; Lin, CY; Maeda, T; Yang, TY | 1 |
2 other study(ies) available for dictamnine and Dermatitis, Atopic
| Article | Year |
|---|---|
Dictamnine ameliorates chronic itch in DNFB-induced atopic dermatitis mice via inhibiting MrgprA3.
Topics: Animals; Dermatitis, Atopic; Dinitrofluorobenzene; Histamine; Mice; Molecular Docking Simulation; Pruritus; Quinolines; Receptors, G-Protein-Coupled; Sensory Receptor Cells; Transient Receptor Potential Channels | 2023 |
Dictamnine delivered by PLGA nanocarriers ameliorated inflammation in an oxazolone-induced dermatitis mouse model.
Topics: Animals; Cytokines; Dermatitis, Atopic; Disease Models, Animal; Inflammation; Mice; NF-kappa B; Oxazolone; Quinolines; Skin; Tumor Necrosis Factor-alpha | 2021 |